Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
NuCana PLC
About NCNA
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-7738 and NUC-3373. NUC-7738 is an anti-cancer agent that disrupts Ribonucleic acid (RNA) polyadenylation, profoundly impacts gene expression in cancer cells and targets multiple aspects of the tumor microenvironment. NUC-7738 is in the Phase II part of a Phase I/II study which is evaluating NUC-7738 as a monotherapy in patients with advanced solid tumors and in combination with pembrolizumab in patients with melanoma. NUC-3373 is a chemical entity derived from the nucleoside analog 5-fluorouracil, a chemotherapy agent. NUC-3373 is being evaluated in a Phase Ib/II modular study (NuTide:303) of NUC-3373 in combination with the PD-1 inhibitor pembrolizumab for patients with advanced solid tumors and in combination with docetaxel for patients with lung cancer.
Find out what a historical investment in NuCana PLC would be worth today using our NCNA stock calculator.
Market Capitalisation
$8.24M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
13.83K
High today
$2.08
Low today
$1.99
Open price
$2.00
52-week high
$40.00
52-week low
$1.33
Ready to start your investing journey with Stake?
Open an accountHow do I buy NCNA shares in Australia?
Buying NCNA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in NuCana PLC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NCNA
What is the ticker symbol of NuCana PLC?
The ticker symbol for NuCana PLC is NCNA.
How much is one share of NCNA?
One share of NCNA is valued at $2.08 as of 21 May 2026.
What is the market capitalisation of NuCana PLC NCNA?
As of 21 May 2026 NuCana PLC has a market cap of $8.24M.
What is the 52-week high for NuCana PLC stock?
The NuCana PLC 52-week high stock price is $40.00.
What is the 52-week low for NuCana PLC stock?
The NuCana PLC 52-week low stock price is $1.33.
Can I buy NCNA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NCNA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in NCNA on Stake
- Buy NCNA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of NCNA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
NCNA related stocks